2.20
Sunshine Biopharma Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
27.3
FY23:
24.9
FY24:
26.0
FY25:
26.9
(positive)
Change from FY21 to FY25
millions USD
FY21:
0.01
FY22:
1.93
FY23:
2.46
FY24:
4.59
FY25:
3.23
Total assets
Change from FY21 to FY25
millions USD
FY21:
2.20
FY22:
29.2
FY23:
27.3
FY24:
30.6
FY25:
30.1
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
0.09
FY22:
6.93
FY23:
5.55
FY24:
6.31
FY25:
6.44
(negative)
Change from FY21 to FY25
millions USD
FY21:
1.90
FY22:
0.69
FY23:
0.59
FY24:
0.74
FY25:
0.60
(positive)
Change from FY21 to FY25
millions USD
FY21:
0.21
FY22:
21.6
FY23:
21.2
FY24:
23.5
FY25:
23.0
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
2.20
FY22:
29.2
FY23:
27.3
FY24:
30.6
FY25:
30.1
All amounts in millions USD